GlucoMe’s Decision Support System (“DSS”) personalizes treatment recommendations ensuring optimal oral drug intensification (2nd and 3rd line) for type 2 diabetes mellitus patients.

GlucoMe, innovating and marketing a comprehensive digital diabetes platform, announced today that it will participate in the Startup Creasphere Batch 2 program by Roche and Plug and Play, to explore a possible collaboration to advance its comprehensive digital diabetes platform.